Acura Pharmaceuticals Inc. (ACUR) News

News for Acura Pharmaceuticals Inc. (ACUR)

Sector News | Topic News

Mon, Jan 23, 2012

4:14 PM

Acura Pharmaceuticals Provides Update on Opioid Product Licensed to Pfizer - Marketwire

Mon, Nov 28, 2011

8:00 AM

Kahn Swick & Foti, LLC Announces Class Action Settlement on Behalf of Purchasers of Publicly-Traded Securities of Acura Pharmaceuticals, Inc. -- ACUR - PR Newswire

Mon, Oct 31, 2011

4:15 PM

Acura Pharmaceuticals Announces Third Quarter 2011 Financial Results - Marketwire

Wed, Oct 19, 2011

5:15 PM

Acura Pharmaceuticals Provides an Update on Impede(TM) Technology - Marketwire

Tue, Oct 18, 2011

12:04 PM

Acura Pharmaceuticals to Present at the BioCentury NewsMakers in the Biotech Industry Conference - Marketwire

Mon, Oct 17, 2011

6:33 AM

Acura Pharmaceuticals Provides Update on Opioid Product Licensed to Pfizer - Marketwire

Mon, Oct 03, 2011

4:15 PM

Acura Pharmaceuticals, Inc. Names J. Bradley Rivet VP of Marketing - Marketwire

Tue, Sep 27, 2011

4:15 PM

Acura Pharmaceuticals Awarded Key U.S. Patent for Abuse Deterrent Drug Formulations - Marketwire

Wed, Sep 07, 2011

4:15 PM

Acura Pharmaceuticals to Present at the 2011 Stifel Nicolaus Healthcare Conference - Marketwire

Mon, Jul 11, 2011

6:15 AM

Robert Jones Appointed President & CEO and to the Board of Directors of Acura Pharmaceuticals, Inc. - Globe Newswire

Fri, Jul 08, 2011

6:15 AM

Acura Pharmaceuticals, Inc. Announces the Retirement of William A. Sumner From Board of Directors - Globe Newswire

Fri, Jul 01, 2011

6:15 AM

Acura Pharmaceuticals Receives $20 Million Milestone Payment - Globe Newswire

Mon, Jun 06, 2011

6:00 AM

Acura Pharmaceuticals, Inc. Announces Notice of Allowance for Third Aversion(R) Technology Patent - Globe Newswire

Mon, May 02, 2011

6:00 AM

Acura Pharmaceuticals, Inc. Announces Appointment of Robert Jones as Interim President and CEO - Globe Newswire

Fri, Apr 29, 2011

4:15 PM

Acura Pharmaceuticals, Inc. Announces the Passing of Andrew Reddick, President & CEO - Globe Newswire

Thu, Apr 28, 2011

4:15 PM

Acura Pharmaceuticals Reports First Quarter 2011 Financial Results and Product Development Update - Globe Newswire

Mon, Apr 25, 2011

4:10 PM

Acura Pharmaceuticals, Inc. Announces Andrew Reddick, President & CEO, to Take Medical Leave - Globe Newswire

Tue, Mar 01, 2011

4:15 PM

Acura Pharmaceuticals Reports Year-End and Fourth Quarter 2010 Financial Results and Product Development Update - Globe Newswire

Financial Market Data powered by QuoteMedia.com. All rights reserved. View the Terms of Use
NYSE/AMEX data delayed 20 minutes. NASDAQ and other data delayed 15 minutes unless indicated.
RT Realtime, EOD End Of Day, PD Previous Day. PW Previous Week.

All information displayed and available herein is on an "as is", "as available" basis and neither InvestorPoint.com nor any of its underlying service providers, information providers, licensors, employees, distributors or agents make any representations as to the suitability of our service or the materials for any purpose. The information is not intended for trading purposes or advice. We specifically disclaim any representations or warranties, express or implied, including, without limitation, any representations or warranties of merchantability or fitness for a particular purpose. InvestorPoint.com is not an investment adviser. We do not: (a) give investment advice, (b) advocate the purchase or sale of any security or investment and (c) provide, endorse or review any information or data contained herein. We do not guarantee the accuracy of the information and data supplied by information providers. We are not liable or responsible for the quality, accuracy or reliability of this information. You should always seek the assistance of a professional for investment advice.